Posts by Sandra Ansanay-Alex
Firmenich inaugurates its new campus in Geneva
The 225,000 m2 site, located in the towns of Satigny and La Plaine, has a largely automated production capacity of 61,000 tonnes per year. It is the largest of the group’s global operations and one of the most technologically advanced. “This investment of nearly CHF 200 million is the most important one Firmenich has…
Read MoreORamaVR raises 2.4M EUR in a post-seed funding round
The leader in medical virtual reality (VR) training tools, based in Geneva, provides immersive virtual reality solutions that allow the training of medical professionals on a large scale The lack of access to affordable surgical care today has created a major health crisis currently affecting almost 5 billion people globally. The World Health Organization…
Read MoreBoneView®, an AI solution to improve fractures diagnostic on X-rays images
Gleamer and HealthCare Konnect (HCK) partner to expand access to AI-Based double check-in fractures, effusions, dislocations and bone lesions on X-Ray images. Healthcare Konnect, a Swiss company dedicated to the distribution of AI-based diagnostic solutions and Gleamer, a French MedTech company that develops a suite of Artificial Intelligence products for radiology, have announced a…
Read MoreRon Appel, SIB’s president, retires
Bioinformatics pioneer gives way to the next generation Ron Appel pioneered the field of bioinformatics in Switzerland and supported the remarkable growth of the discipline over the years, with SIB becoming one of the world’s leading institutes in the field. Co-founder of SIB in 1998, Ron Appel became its Executive Director in 2007. He then shared…
Read MoreArcoScreen and DAAV are FIT
ArcoScreen and DAAV both receive a Tech Seed loan of CHF 100’000 from the Foundation for Technological Innovation (FIT). ArcoScreen provides a solution to simplify the identification of promising drugs and DAAV develops a wheelchair to facilitate mobility for people with mobility issues in places such as airports. ArcoScreen Arcoscreen’s mission is to help pharmaceutical…
Read MoreProgress in the diagnosis of endometriosis
Researchers from the University of Bern and Inselspital and University Hospital Bern, in collaboration with Australian scientists, are developing a rapid and non-invasive endometriosis test using menstrual samples. Endometriosis is a disease of the endometrium that affects 10 to 15 percent of girls and women of childbearing age. Typical symptoms include severe abdominal pain…
Read MoreFlowbone SA concludes a CHF 2.1 million Seed round
The EPFL spin-off, active in the field of bone regeneration, prepares its US market entry. “With aging population, fractures resulting from osteoporosis will significantly increase. Since current osteoporosis drugs have only limited efficacy in the hip region, there is an urgent need for a complimentary, local, and simple procedure to build up bone mass…
Read MoreA UNIGE team reveals how Hepatitis B could be cured
The swiss🇨🇭 researchers have deciphered the precise functioning of a protective mechanism that could lead to a potential post-infection treatment The hepatitis B virus (HBV) is responsible for one of the most serious and common infectious diseases. Transmitted through biological fluids, it attacks the liver cells. The chronic form of the disease can lead…
Read MoreFour Swiss🇨🇭 start-ups in the Top 18 European TechBio companies
ONWARD, Haya Therapeutics, Retinai and Engimmune Therapeutics are in the top 18 Biotech companies in Europe according to investors. Stuck in the middle… raising funds can be hard for biotech start-ups… Biotech investors may not get the tech bit, while tech investors don’t get the bio bit. Sifted asked investors who ventured into the TechBio world…
Read MoreVolumina Medical closes its Series A funding to develop Adipearl
Clinique La Prairie and Skyviews Life Science Ltd are among the new investors Volumina Medical, a spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL) specializing in developing innovative biomaterials announced that it has raised an undisclosed amount in a Series A fundraising. Around 2 million women are diagnosed with breast cancer…
Read More